Next-Generation Immunotherapies
Mana Therapeutics has raised $7.5M in total funding. The most recent round was Debt Financing. The last funding was announced in November 2021.
Mana Therapeutics's investors include Silicon Valley Bank, LifeSci Venture Partners, SK Securities, Lightchain, Cobro Ventures.
Mana Therapeutics is headquartered in Arlington, United States.
Next-Generation Immunotherapies
Mana Therapeutics is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Mana Therapeutics — Funding & Investors." VCBacked, November 30, 2021, https://www.vcbacked.co/company/mana-therapeutics. Accessed September 30, 2026.
VCBacked. (2021). Mana Therapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/mana-therapeutics
{{cite web |title=Mana Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/mana-therapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated